Nazareno, Melodia L.

HRN: 22-92-78  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/24/2023
05/08/2023
IV
1.5grams
Q6hours
Empiric
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: